Table 2.
Variables | HR | 95% CI | P value |
---|---|---|---|
Male | 0.794 | 0.563–1.121 | 0.19 |
BMI | 0.943 | 0.899–0.989 | 0.016 |
Diabetes | 1.375 | 0.977–1.936 | 0.068 |
History of stroke | 0.190 | 0.840–2.396 | 1.419 |
Type of AMI | 1.378 | 0.966–1.966 | 0.077 |
Heart failure | 4.640 | 2.352–9.151 | <0.001 |
Hypertension | 0.896 | 0.625–1.823 | 0.547 |
CTNI | 1.016 | 1.013–1.019 | <0.001 |
CK-MB | 1.002 | 1.001–1.003 | 0.005 |
Aspirin | 0.544 | 0.333–0.887 | 0.015 |
Statins | 0.248 | 0.133–0.460 | <0.001 |
High NLR | 5.327 | 3.720–7.628 | <0.001 |
High PLR | 2.064 | 1.462–2.915 | <0.001 |
eGFR>60(REF) | |||
30~60 | 3.465 | 2.256–5.320 | <0.001 |
<30 | 4.461 | 2.959–6.724 | <0.001 |
Notes: High NLR = NLR > 6.69; High PLR = PLR >187.6; Type of AMI includes NSTEMI and STEMI, Non-ST-segment elevation myocardial infarction was used as a reference.
Abbreviations: NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio; AMI, acute myocardial infarction; BMI, body mass index; CTNI, cardiac troponin I; CK-MB creatine kinase-MB; eGFR, estimated glomerular filtration rate.